111, Inc. YI NASDAQ

NASDAQ Global Market • Healthcare • Medical - Pharmaceuticals • CN • USD

SharesGrow Score

29/100

1/5 Pass

SharesGrow Intrinsic Value

$32.89

+383%

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

111, Inc. (YI) has a negative trailing P/E of -5.4, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -18.37%.

Criteria proven by this page:

VALUE (0/100, Fail) — negative P/E indicates the company is currently operating at a loss — DCF and P/E-based valuation models cannot produce meaningful results for unprofitable companies (P/E -5.4); trailing earnings yield is below the 10-year Treasury yield (~4.3%), meaning bonds offer a better return (EY -18.37%).
Trailing Earnings Yield -18.37% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings.

Overall SharesGrow Score: 27/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score

29/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

0/100

→ Income

✗

HEALTH

25/100

Debt-to-Equity & liquidity

→ Health

✗

MOAT

27/100

→ Income

✓

GROWTH

83/100

→ Income

✗

INCOME

10/100

→ Income

Valuation Snapshot — YI

Valuation Multiples

P/E (TTM)-5.4

Forward P/EN/A

PEG RatioN/A

Forward PEGN/A

P/B Ratio-0.56

P/S Ratio0.03

EV/EBITDA34.2

Per Share Data

EPS (TTM)$-8.04

Book Value / Share$25.12

Revenue / Share$1,559.38

FCF / Share$-1.44

Yields & Fair Value

Earnings Yield-18.37%

Dividend Yield0.00%

SharesGrow IV$32.89 (+383%)

Historical Valuation

Year	P/E (TTM)	PEG Ratio	P/B Ratio	P/S Ratio	Dividend Yield
2016	-8.3	0.00	5.22	3.43	-
2017	-13.0	0.32	10.18	3.37	-
2018	-5.5	-0.52	1.71	1.18	-
2019	-7.6	0.36	4.94	0.97	-
2020	-8.2	1.03	10.45	0.46	-
2021	-2.8	-0.06	-10.64	0.15	-
2022	-4.2	0.11	-4.19	0.13	-
2023	-2.4	0.34	-1.59	0.06	-
2024	-6.1	0.07	-0.61	0.03	-

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2016	$-100.74	$873.84M	$-362.68M	-41.5%
2017	$-69.04	$959.49M	$-248.58M	-25.9%
2018	$-76.44	$1.79B	$-380.09M	-21.3%
2019	$-60.16	$3.95B	$-492.39M	-12.5%
2020	$-55.72	$8.2B	$-459.04M	-5.6%
2021	$-79.94	$12.43B	$-662.97M	-5.3%
2022	$-49.02	$13.52B	$-408.5M	-3%
2023	$-46.58	$14.95B	$-392.69M	-2.6%
2024	$-7.52	$14.4B	$-64.74M	-0.4%